Screener
ADMA Biologics ADMA EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's EBITDA?
- ADMA Biologics (ADMA) reported EBITDA of $54.15M in Q2 2026.
- How has ADMA Biologics's EBITDA changed year-over-year?
- ADMA Biologics's EBITDA increased by 20.9% year-over-year, from $44.8M to $54.15M.
- What is the long-term trend for ADMA Biologics's EBITDA?
- Over 4 years (2021 to 2025), ADMA Biologics's EBITDA has grown at a 39.3% compound annual growth rate (CAGR), from -$52.88M to $199.34M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about ADMA Biologics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude